Bank of Montreal’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,692
Closed -$18K 5212
2021
Q1
$18K Sell
2,692
-5,523
-67% -$39.8K ﹤0.01% 4110
2020
Q4
$51K Buy
8,215
+4,717
+135% +$27.8K ﹤0.01% 3930
2020
Q3
$19K Sell
3,498
-1,199
-26% -$5.94K ﹤0.01% 3870
2020
Q2
$25K Buy
4,697
+1,981
+73% +$8.8K ﹤0.01% 3757
2020
Q1
$8K Sell
2,716
-4,257
-61% -$15.7K ﹤0.01% 3571
2019
Q4
$28K Sell
6,973
-508
-7% -$1.76K ﹤0.01% 4127
2019
Q3
$32K Sell
7,481
-335
-4% -$1.34K ﹤0.01% 3838
2019
Q2
$31K Buy
7,816
+6,520
+503% +$31K ﹤0.01% 3922
2019
Q1
$7K Sell
1,296
-227
-15% -$1.47K ﹤0.01% 3977
2018
Q4
$8K Buy
1,523
+1,166
+327% +$8.85K ﹤0.01% 3962
2018
Q3
$3K Buy
357
+133
+59% +$1.34K ﹤0.01% 4277
2018
Q2
$2K Sell
224
-10,200
-98% -$115K ﹤0.01% 4428
2018
Q1
$136K Buy
10,424
+10,359
+15,937% +$154K ﹤0.01% 2830
2017
Q4
$1K Hold
65
﹤0.01% 4122
2017
Q3
$2K Hold
65
﹤0.01% 4057
2017
Q2
$2K Hold
65
﹤0.01% 4046
2017
Q1
$1K Buy
+65
New +$1.02K ﹤0.01% 3910

Other funds holding PRTK

Bank of Montreal's PRTK Position: Q2 2021 in Review

Bank of Montreal sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q2 2021, closing a stake of 2,692 shares — an estimated $18K sold.

Bank of Montreal first reported a position in PRTK in Q1 2017 and held it in 17 quarters. The position peaked at $136K in Q1 2018. 116 funds tracked by Wall St. Rank hold PRTK as of Q2 2021.

  • Bank of Montreal reported no remaining Paratek Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 2,692 Paratek Pharmaceuticals, Inc. shares in Q2 2021, an estimated $18K.
  • Bank of Montreal first reported a position in Paratek Pharmaceuticals, Inc. in Q1 2017 and held it in 17 quarters.
  • Bank of Montreal's Paratek Pharmaceuticals, Inc. position peaked at $136K in Q1 2018.
  • 116 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.